Follow-The-Filings

Security · featured owners

NMRA Neumora Therapeutics Inc.

COM Equity as of 2026 Q2 among managers we track

  • 1 exit

holders

sorted by value · long equity only · current book 2026 Q2 · open a manager for their book

history
Nathan Fischel - Dafna Capital Management exited 2026 Q2 last 2026 Q1 0.03% Exit −0.03 pp 70,000 $137K history

SEC filings

Recent issuer filings from EDGAR · 16 shown · open Filing / Doc on SEC.gov

Filed Form Detail Links
8-K 2.02,5.02,9.01
10-Q
8-K 8.01,9.01
8-K 1.01,2.03,2.05,7.01,8.01,9.01
8-K 5.07
8-K 2.02,9.01
10-Q
DEFA14A
8-K 2.02,9.01
10-K
8-K 7.01,9.01
8-K 7.01,9.01
8-K 8.01,9.01
8-K 3.02,9.01
8-K 2.02,9.01
10-Q

Insider forms

Form 3 / 4 / 5 from EDGAR · 7 rows shown

Filed Form Detail Links
4 Period Aug 20, 2026 · 5 forms
4 Period Aug 17, 2026
4 Period May 27, 2026 · 5 forms
4 Period Feb 17, 2026 · 4 forms
4 Period Jan 8, 2026 · 5 forms
4 Period Nov 11, 2025
4 Period Oct 27, 2025 · 3 forms

financials

US-GAAP annual · as tagged in Form 10-K · fiscal years · values link to the SEC filing

Income statement

Metric FY2023 FY2024 FY2025
Net income -$235.92M -$243.79M -$236.93M

Balance sheet

Metric FY2023 FY2024 FY2025
Total current assets $478.28M $314.06M $190.54M
Total non-current assets * $17.92M $2.92M $0.51M
Total assets $496.2M $316.97M $191.05M
Total current liabilities $25.11M $29.89M $32.45M
Total non-current liabilities * $2.01M $0.022M $54.72M
Total equity $469.08M $287.06M $103.87M

Cash flow

Metric FY2023 FY2024 FY2025
Cash from operations -$163.28M -$182.94M -$206.44M
Cash from investing $64.39M -$70.56M $168.52M
Cash from financing $231.94M $21.6M $77.09M
Net change in cash $133.04M -$231.89M $39.17M

ownership over time

filing count by report period · click a bar for that quarter’s holders